Cardura: Effective Blood Pressure and BPH Symptom Control

Cardura

Cardura

Cardura is consumed to rebalance the blood pressure within hypertension, as well as to cure benign prostatic hyperplasia (BPH). This drug was not distinguished by a negative effect on the metabolism, which was often recorded in analogs. That’s why Cardura earned positive reviews from people suffering from cardiovascular insufficiency, asthma, diabetes.
Product dosage: 1mg
Package (num)Per pillPriceBuy
120$0.33$40.00 (0%)πŸ›’ Add to cart
180$0.31$60.00 $56.00 (7%)πŸ›’ Add to cart
270$0.29$90.00 $78.00 (13%)πŸ›’ Add to cart
360
$0.26 Best per pill
$120.00 $94.00 (22%)πŸ›’ Add to cart
Product dosage: 2mg
Package (num)Per pillPriceBuy
60$0.87$52.00 (0%)πŸ›’ Add to cart
90$0.79$78.00 $71.00 (9%)πŸ›’ Add to cart
120$0.76$104.00 $91.00 (12%)πŸ›’ Add to cart
180$0.72$156.00 $130.00 (17%)πŸ›’ Add to cart
270$0.70$234.00 $189.00 (19%)πŸ›’ Add to cart
360
$0.67 Best per pill
$312.00 $241.00 (23%)πŸ›’ Add to cart

Cardura (doxazosin mesylate) is an alpha-1 adrenergic blocker prescription medication clinically proven to manage two significant conditions: hypertension (high blood pressure) and the symptoms of benign prostatic hyperplasia (BPH). By selectively relaxing smooth muscle in blood vessel walls and the prostate gland, it facilitates improved blood flow and easier urination. This dual-action mechanism offers a targeted therapeutic approach for patients requiring management of these often co-occurring conditions, providing a foundation for enhanced cardiovascular and urological health under proper medical supervision.

Features

  • Active pharmaceutical ingredient: Doxazosin mesylate
  • Medication class: Selective alpha-1 adrenergic receptor antagonist
  • Available in oral tablet formulations (standard and extended-release)
  • Standard tablet strengths: 1 mg, 2 mg, 4 mg, 8 mg
  • Extended-release (XL) tablet strengths: 4 mg, 8 mg
  • Works by relaxing vascular smooth muscle and smooth muscle in the prostate and bladder neck

Benefits

  • Effectively lowers elevated blood pressure, reducing long-term strain on the heart and cardiovascular system.
  • Significantly improves urinary flow and reduces symptoms of BPH, such as hesitancy, weak stream, and nocturia.
  • Provides a single therapeutic option for patients diagnosed with both hypertension and symptomatic BPH.
  • The extended-release formulation allows for once-daily dosing, potentially improving medication adherence.
  • Demonstrated efficacy in a well-established patient population through extensive clinical use and studies.

Common use

Cardura is primarily indicated for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents such as diuretics or beta-blockers. It is also indicated for the symptomatic treatment of benign prostatic hyperplasia (BPH). BPH is a non-cancerous enlargement of the prostate gland that can cause obstructive and irritative urinary symptoms. Cardura helps to relieve these symptoms by relaxing the smooth muscle in the prostate and bladder neck, thereby improving urine flow and reducing bladder outlet obstruction. It is important to note that while Cardura treats the symptoms of BPH, it does not reduce the size of the prostate itself.

Dosage and direction

For Hypertension:

  • The initial dosage is typically 1 mg administered once daily.
  • The dosage may be increased gradually based on the patient’s blood pressure response and tolerability. Dosage adjustments are usually made at 1-2 week intervals.
  • The usual therapeutic dosage range is 2-8 mg once daily. The maximum recommended dosage is 16 mg per day, though most patients respond to 8 mg or less.
  • It can be taken in the morning or evening, but consistency in timing is important. Taking the first dose at bedtime is often recommended to minimize the potential for initial orthostatic effects.

For Benign Prostatic Hyperplasia (BPH):

  • The initial dosage is 1 mg administered once daily.
  • Dosage may be increased to 2 mg, 4 mg, and 8 mg once daily, based on the patient’s clinical response and tolerability. The recommended titration interval is 1-2 weeks.
  • The usual recommended therapeutic dosage is 4-8 mg once daily.

For Cardura XL (Extended-Release):

  • The recommended initial dose is 4 mg taken once daily with breakfast.
  • The dose may be increased to 8 mg based on clinical response after 3-4 weeks.
  • Tablets must be swallowed whole and must not be crushed, chewed, or divided.

Dosage must be individualized and determined by a healthcare professional. The antihypertensive effect of a single dose persists for 24 hours.

Precautions

  • First-Dose Effect: A marked drop in blood pressure, especially with standing (orthostatic hypotension), with associated dizziness, palpitations, and, in rare cases, syncope (fainting), can occur within 2-6 hours after the first dose or any subsequent rapid dose increase. This risk is minimized by starting with a 1 mg dose and taking it at bedtime.
  • Orthostatic Hypotension: Symptoms of lowered blood pressure upon standing (dizziness, lightheadedness) can occur at any time during treatment, particularly after a dosage increase. Patients should be cautious when rising from a sitting or lying position.
  • Priapism: Prolonged and painful erections have been reported with this class of drugs. This condition requires immediate medical attention to prevent permanent tissue damage.
  • Intraoperative Floppy Iris Syndrome (IFIS): This alpha-1 blocker class effect has been observed during cataract surgery. Surgeons should be informed in advance of planned surgery that the patient is taking doxazosin.
  • Use in Specific Populations: Use with caution in patients with severe renal or hepatic impairment. Safety and efficacy in children have not been established.

Contraindications

Cardura is contraindicated in patients with a known hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any component of the formulation.

Possible side effect

Like all medications, Cardura can cause side effects, although not everybody gets them. Common side effects are often related to its pharmacological action and may include:

  • Dizziness (15.6%)
  • Fatigue (8.2%)
  • Headache (7.8%)
  • Somnolence (drowsiness) (5.4%)
  • Nausea (3.9%)
  • Edema (fluid retention, swelling) (3.1%)
  • Rhinitis (nasal congestion) (2.9%)
  • Hypotension (low blood pressure) (1.7%)
  • Palpitations (1.3%)
  • Postural dizziness (1.0%)

Less common but more serious side effects require immediate medical attention and can include:

  • Syncope (fainting)
  • Symptoms of severe hypotension (e.g., severe dizziness, fainting)
  • Priapism (prolonged, painful erection)
  • Signs of an allergic reaction (hives, difficulty breathing, swelling of the face or throat)

Drug interaction

Cardura can interact with other medications, which may alter its effects or increase the risk of serious side effects. It is crucial to inform your doctor of all medicines you use, including prescription, over-the-counter, and herbal products.

  • Other Blood Pressure-Lowering Agents: Concomitant use with other antihypertensives (e.g., diuretics, beta-blockers, ACE inhibitors, calcium channel blockers) or phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil for erectile dysfunction) may potentiate the blood pressure-lowering effects and increase the risk of hypotension.
  • CYP3A4 Inhibitors: Strong inhibitors of the liver enzyme CYP3A4 (e.g., ketoconazole, itraconazole, ritonavir) may increase plasma concentrations of doxazosin, increasing the risk of adverse effects. Caution is advised.
  • NSAIDs: Nonsteroidal anti-inflammatory drugs (e.g., ibuprofen, naproxen) may reduce the antihypertensive effect of doxazosin.

Missed dose

If a dose is missed, it should be taken as soon as remembered on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Do not take a double dose to make up for a missed one.

Overdose

In the event of an overdose, the primary expected manifestation is severe hypotension, which may present with profound dizziness, lightheadedness, and syncope. Supportive care is the mainstay of treatment. This includes placing the patient in a supine position, monitoring vital signs, and administering IV fluids and vasopressors if necessary. Gastric lavage or activated charcoal may be considered if ingestion was very recent. Symptomatic and supportive measures should be implemented as required. Management of overdose should be conducted in a medical facility.

Storage

Store Cardura tablets at room temperature, between 20Β°C to 25Β°C (68Β°F to 77Β°F), in a tightly closed container. Excursions are permitted between 15Β°C and 30Β°C (59Β°F and 86Β°F). Keep the medication in its original container, away from light, excess moisture, and heat. Keep all medications out of the reach of children and pets.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.

Reviews

“After starting Cardura for my BPH, the difference in urinary flow was noticeable within a couple of weeks. The frequent nighttime trips to the bathroom reduced significantly, greatly improving my sleep quality. The initial dizziness was manageable by taking the pill right before bed.” – John D., 68

“My physician prescribed Cardura for hypertension alongside my existing regimen. It was the addition that finally got my numbers into a stable, healthy range. I experienced some mild fatigue at the beginning, but it subsided after the first month.” – Maria S., 59

“While effective for my symptoms, the side effects of dizziness and lightheadedness were too disruptive for my active lifestyle. I had to work closely with my urologist to find an alternative treatment option.” – Robert T., 71